ADENTRA Inc. (TSE:ADEN) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of ADENTRA Inc. (TSE:ADENGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the six analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company.

A number of equities research analysts recently commented on the company. Canadian Imperial Bank of Commerce lifted their price objective on ADENTRA from C$41.00 to C$42.00 in a research note on Tuesday, November 11th. National Bank Financial increased their target price on ADENTRA from C$42.50 to C$54.50 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Stifel Nicolaus boosted their target price on ADENTRA from C$47.00 to C$51.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Scotiabank upped their price target on ADENTRA from C$41.00 to C$46.00 in a research note on Thursday, January 29th. Finally, Raymond James Financial lifted their price objective on shares of ADENTRA from C$43.00 to C$46.00 in a research note on Tuesday, November 11th.

View Our Latest Analysis on ADENTRA

ADENTRA Stock Performance

Shares of ADEN stock opened at $39.23 on Wednesday. The firm’s 50 day moving average price is $36.78 and its two-hundred day moving average price is $34.91. ADENTRA has a 52-week low of $24.60 and a 52-week high of $41.20. The stock has a market cap of $950.03 million, a PE ratio of 22.29 and a beta of 1.56.

ADENTRA Company Profile

(Get Free Report)

Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.

Featured Stories

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.